publication date: Nov. 18, 2011
ACS Creates $1 Billion Nationwide Organization, Taking Fiduciary Control From 12 Divisions With no budget in sight, NCI takes careful steps; Success Rate last year was 14 percent FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication Industry Groups Lobby for Lower Standards for FDA Approval Download PDF
Documents referenced in this issue of The Cancer Letter can be found here
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.